JPWO2022012681A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022012681A5
JPWO2022012681A5 JP2023502590A JP2023502590A JPWO2022012681A5 JP WO2022012681 A5 JPWO2022012681 A5 JP WO2022012681A5 JP 2023502590 A JP2023502590 A JP 2023502590A JP 2023502590 A JP2023502590 A JP 2023502590A JP WO2022012681 A5 JPWO2022012681 A5 JP WO2022012681A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
cdr1
cdr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023502590A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023546766A5 (https=
JP2023546766A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/106889 external-priority patent/WO2022012681A1/en
Publication of JP2023546766A publication Critical patent/JP2023546766A/ja
Publication of JP2023546766A5 publication Critical patent/JP2023546766A5/ja
Publication of JPWO2022012681A5 publication Critical patent/JPWO2022012681A5/ja
Pending legal-status Critical Current

Links

JP2023502590A 2020-07-16 2021-07-16 多重特異性キメラ抗原受容体及びその使用 Pending JP2023546766A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2020/102470 2020-07-16
CN2020102470 2020-07-16
PCT/CN2021/106889 WO2022012681A1 (en) 2020-07-16 2021-07-16 Multispecific chimeric antigen receptors and uses thereof

Publications (3)

Publication Number Publication Date
JP2023546766A JP2023546766A (ja) 2023-11-08
JP2023546766A5 JP2023546766A5 (https=) 2024-07-11
JPWO2022012681A5 true JPWO2022012681A5 (https=) 2024-07-11

Family

ID=79554495

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023502590A Pending JP2023546766A (ja) 2020-07-16 2021-07-16 多重特異性キメラ抗原受容体及びその使用

Country Status (9)

Country Link
US (1) US20230257475A1 (https=)
EP (1) EP4182356A4 (https=)
JP (1) JP2023546766A (https=)
KR (1) KR20230040333A (https=)
CN (1) CN116390941A (https=)
AU (1) AU2021308745A1 (https=)
CA (1) CA3189531A1 (https=)
IL (1) IL299865A (https=)
WO (1) WO2022012681A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7846667B2 (ja) * 2020-07-16 2026-04-15 レジェンド バイオテック アイルランド リミテッド Cd20結合分子及びその使用
CN114478803B (zh) * 2022-02-11 2023-09-26 北京大学深圳研究生院 一种新型双特异性嵌合抗原受体的构建及其应用
WO2024173607A2 (en) * 2023-02-14 2024-08-22 Evolveimmune Therapeutics, Inc. Combination of bispecific antibodies and chimeric antigen receptor t cells for treatment
WO2025049972A1 (en) * 2023-09-01 2025-03-06 Cargo Therapeutics, Inc. Compositions and methods for immunotherapies
WO2025146143A1 (zh) * 2024-01-05 2025-07-10 南京传奇生物科技有限公司 治疗自身免疫疾病的方法
WO2025214438A1 (zh) * 2024-04-10 2025-10-16 浙江纳米抗体技术中心有限公司 结合cd19和/或cd22的抗原结合分子及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0624500D0 (en) * 2006-12-07 2007-01-17 Istituto Superiore Di Sanito A novel passive vaccine for candida infections
KR20150029714A (ko) * 2012-07-13 2015-03-18 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 이중특이적 항체의 공-도입에 의한 car 세포의 활성 증강
CA2874083C (en) * 2014-12-05 2024-01-02 Universite Laval Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
CN105384825B (zh) * 2015-08-11 2018-06-01 南京传奇生物科技有限公司 一种基于单域抗体的双特异性嵌合抗原受体及其应用
US11248057B2 (en) * 2016-03-07 2022-02-15 Vib Vzw CD20 binding single domain antibodies
EP4282877A3 (en) * 2016-08-10 2024-02-21 Legend Biotech Ireland Limited Chimeric antigen receptors targeting bcma and methods of use thereof
CN112888709B (zh) * 2018-03-30 2024-10-29 优瑞科生物技术公司 标靶cd22的构建体和其用途
WO2020087116A1 (en) * 2018-10-30 2020-05-07 Peter Maccallum Cancer Institute Bispecific polypeptides for engagement of car expressing immune cells with antigen presenting cells and uses thereof
CN111217908B (zh) * 2019-11-29 2021-07-06 深圳普瑞金生物药业有限公司 Cd22单域抗体、核苷酸序列、试剂盒、car-t病毒载体及car-t细胞
CN110922482B (zh) * 2019-12-25 2021-08-31 源道隆(苏州)医学科技有限公司 可结合cd19的多肽及其应用

Similar Documents

Publication Publication Date Title
JP2025028239A5 (https=)
JP2021094037A5 (https=)
FI3334765T3 (fi) Yksidomeenivasta-aineisiin perustuvia kimeerisiä antigeenireseptoreita ja menetelmiä niiden käyttämiseksi
JP2018525033A5 (https=)
KR20230143177A (ko) 신규한 항-cd24 항체
CA3020864A1 (en) Novel b7-h3-binding molecules, antibody drug conjugates thereof and methods of use thereof
JP7503642B2 (ja) 微小ガイダンス及びナビゲーションコントロール(miniGNC)抗体様タンパク質、その製造方法及び使用方法
CN110167591B (zh) Adam9结合分子及使用其的方法
US20250270315A1 (en) Novel anti-sirpa antibodies
CA3258731A1 (en) NEW ANTI-LIRB4 ANTIBODIES AND THEIR USES
US20240228641A9 (en) Antibodies binding to cd30 and cd3
WO2024041315A1 (en) Novel anti-lilrb2 antibodies and uses thereof
JPWO2019245991A5 (https=)
JPWO2022012681A5 (https=)
JPWO2022012683A5 (https=)
JPWO2022012680A5 (https=)
JPWO2022127871A5 (https=)
HK40073541A (en) Miniature guidance and navigation control (minignc) antibody-like proteins and methods of making and using thereof
EA052500B1 (ru) Новые антитела против cd24
JP2024539550A (ja) ヒト化抗egfrviii抗体及びその抗原結合断片
JPWO2023186873A5 (https=)